Displaying 1 - 20 of 20
| Active Ingredient | OMALIZUMAB |
| Therapeutic Class | RESPIRATORY INFLAMMATORY AGENTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | RESPIRATORY INFLAMMATORY AGENTS |
| Therapeutic Class | RESPIRATORY INFLAMMATORY AGENTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BECLOMETHASONE |
| Therapeutic Class | CORTICOSTEROIDS (RESPIRATORY) |
| Indications | Prophylaxis of asthma. |
| Caution |
Hoarseness, candidiasis of mouth or throat. . Rinse mouth with water after inhalation. |
| Dose Range | Adult: 2 puffs 3-4 times daily. Pediatric 6 yrs and over: 1-2 puffs 2-4 times daily. See BDS supply protocols pg. 9. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BUDESONIDE |
| Therapeutic Class | CORTICOSTEROIDS (RESPIRATORY) |
| Indications | Treatment of asthma. |
| Caution | Rinse mouth with water after inhalation. |
| Dose Range |
Adult and Children over 6 years: 1-2 puffs twice daily. See BDS supply protocols pg. 9. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUTICASONE |
| Therapeutic Class | CORTICOSTEROIDS (RESPIRATORY) |
| Indications | Asthma. |
| Caution | Headache, pharyngitis, nasal congestion, dysphonia and oral candidiasis. Rinse mouth with water after inhalation.nNot recommended for children under 1 year. |
| Dose Range | Adult and Children 4 years and over: 50-1000mcg twice daily . Pediatric 1-3 yrs: 50-100mcg twice daily. See BDS supply protocols pg. 10. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | MONTELUKAST |
| Therapeutic Class | LEUKOTRIENE MODIFIERS |
| Indications | Management of asthma. |
| Caution | Abdominal pain; headache; hyperkinesia (in young children); thirst |
| Dose Range | Adult and children 15 years and over: 10 mg once daily. Pediatric: 6 months–5 years: 4 mg once daily ; 6–14 years: 5 mg once daily . Dose to be taken in the evening. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | KETOTIFEN |
| Therapeutic Class | MAST CELL STABILISERS |
| Indications | Prophylaxis of asthma. Atopic asthma in children. |
| Caution | Drowsiness dry mouth, dizziness, weight gain. C.f. prescribing in liver disease p. 14. |
| Dose Range | Adult: 1-2mg twice daily with food. Pediatric 3 yrs and over: 1mg twice daily . See BDS supply protocols pg. 8. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FENOTEROL |
| Therapeutic Class | SELECTIVE BETA2 ADRENERGIC AGONIST (RESPIRATORY) |
| Indications |
For the symptomatic relief of bronchospasm in bronchial asthma and bronchitis. |
| Caution | Because of longer duration of action when compared to other beta 2 agonists, dosage should be carefully monitored. Tachycardia, palpitations, tremor, nervousness. |
| Dose Range |
Adult: 200-400 micrograms (1-2 p uffs) 3 times daily . See BDS supply protocols pg. 10. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding | Fenoterol is distributed into breast milk. |
| Active Ingredient | SALBUTAMOL |
| Therapeutic Class | SELECTIVE BETA2 ADRENERGIC AGONIST (RESPIRATORY) |
| Indications | Bronchospasm. |
| Caution | Tachycardia, palpitations, tremor, nervousness, headache, insomnia,nausea. |
| Dose Range |
Aerosol: 1-3 puffs, 3-4 times daily. Syrup: 1 month- 2 yrs: 100 mcg/kg (max.2 mg) 3-4 times daily ; 2- 6 yrs: 1- 2 mg 3-4 times daily. s.c or i.m inj: 0.5mg repeated every 4 hours if necessary. See BDS supply protocols pg. 10 |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | SALMETEROL |
| Therapeutic Class | SELECTIVE BETA2 ADRENERGIC AGONIST (RESPIRATORY) |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | IPRATROPIUM BROMIDE |
| Therapeutic Class | ANTICHOLINERGIC AGENTS (RESPIRATORY) |
| Indications | Chronic obstructive pulmonary disease unresponsive to beta 2 agonists. |
| Caution | Glaucoma, dry mouth, bitter taste. |
| Dose Range |
Adult: 1-2 puffs 3-4 times daily up to 4 puffs. Pediatric: 1-2 puffs 3 times daily . See BDS supply protocols pg. 10. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | OLODATEROL | TIOTROPIUM |
| Therapeutic Class | ANTICHOLINERGIC AGENTS (RESPIRATORY) |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TIOTROPIUM |
| Therapeutic Class | ANTICHOLINERGIC AGENTS (RESPIRATORY) |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TIOTROPIUM BROMIDE |
| Therapeutic Class | ANTICHOLINERGIC AGENTS (RESPIRATORY) |
| Indications | Maintenance and treatment of reversible airways obstruction seen in chronic obstructive pulmonary disease and asthma. Must be prescribed by a pulmonologist. |
| Caution | Pharyngitis, sinusitis, rhinitis, and epistaxis. |
| Dose Range | Once daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TIOTROPIUM | OLODATEROL |
| Therapeutic Class | ANTICHOLINERGIC AGENTS (RESPIRATORY) |
| Indications | As for Vilanterol/Fluticasone (See p. 365).Prophylaxis of asthma; Long-term maintenance of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). |
| Caution | As for Vilanterol/Fluticasone.Close monitoring for glaucoma and cataracts is warranted. Do not use in combination with an additional LABA because of risk ofoverdose. Naso-pharyngitis, upper respirator More ... |
| Dose Range | Two puffs once daily, at the same time each day . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | AMMONIUM CHLORIDE | CHLORPHENIRAMINE |
| Therapeutic Class | EXPECTORANTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CHLORPHENIRAMINE | AMMONIUM CHLORIDE |
| Therapeutic Class | EXPECTORANTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DEXTROMETHORPHAN |
| Therapeutic Class | EXPECTORANTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DEXTROMETHORPHAN | GUAIFENESIN |
| Therapeutic Class | EXPECTORANTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | AMINOPHYLLINE |
| Therapeutic Class | RESPIRATORY SMOOTH MUSCLE RELAXANTS |
| Indications | Bronchospasm. Acute asthma. |
| Caution | As for theophylline. |
| Dose Range | i.v.; 250-500mg by slow i.v. injection over 20 minutes. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding | Present in milk—irritability in infant reported; modified-release preparations a More ... |